Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: Letter

Cue Health Evaluating Warning Letter Received from Food and Drug Administration (FDA)


Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company (the "Company"), has received a warning letter from the FDA about its Emergency Use Authorized (EUA) COVID-19 test. The Company is currently evaluating the letter and determining its response, with more information to follow in the next few days.

About Cue

Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology company that empowers healthcare providers to streamline their ability to deliver value-based care with fast, highly accurate test results on demand. Cue received De Novo authorization from the U.S. Food and Drug Administration (FDA) for its COVID-19 test, which became the first home use respiratory test to receive this FDA approval. Cue also received Emergency Use Authorization from the FDA for its molecular Mpox test at the point-of-care. Cue, founded in 2010, holds over 100 patents and is headquartered in San Diego. For more information, please visit www.cuehealth.com.


These press releases may also interest you

at 18:00
The global liquid hand soap market size is estimated to grow by USD 2.43 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 8.96% during the forecast period. Increasing cases of transmission of...

at 17:45
The global live music market size is estimated to grow by USD 35.56 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 17.38%  during the forecast period. Growing demand for live music experiences is driving...

at 17:20
The global industrial thermostatic control valves market size is estimated to grow by USD 275.3 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 4.27% during the forecast period. Increased automation...

at 17:00
Camber Energy, Inc. ("Camber" or the "Company") announces with great sadness that its Director, Lawrence (Larry) B. Fisher, has passed away after a brief illness. Mr. Fisher served as a director of the Company since December...

at 16:38
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19...

at 12:05
Vertex Pharmaceuticals Incorporated today announced that data on TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor), also known in the European Union and in the U.K. as KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in combination with...



News published on and distributed by: